KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Operating Leases (2020 - 2025)

AbCellera Biologics' Operating Leases history spans 6 years, with the latest figure at $137.1 million for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases rose 106.8% year-over-year to $137.1 million, compared with a TTM value of $137.1 million through Sep 2025, up 106.8%, and an annual FY2024 reading of $65.4 million, down 8.22% over the prior year.
  • Operating Leases for Q3 2025 was $137.1 million at AbCellera Biologics, roughly flat from $137.2 million in the prior quarter.
  • The five-year high for Operating Leases was $137.2 million in Q2 2025, with the low at $17.0 million in Q1 2021.
  • Average Operating Leases over 5 years is $65.3 million, with a median of $66.5 million recorded in 2024.
  • Year-over-year, Operating Leases skyrocketed 880.16% in 2021 and then dropped 14.89% in 2024.
  • Tracing ABCL's Operating Leases over 5 years: stood at $36.4 million in 2021, then soared by 125.9% to $82.3 million in 2022, then decreased by 13.42% to $71.2 million in 2023, then fell by 8.22% to $65.4 million in 2024, then skyrocketed by 109.68% to $137.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Operating Leases are $137.1 million (Q3 2025), $137.2 million (Q2 2025), and $63.2 million (Q1 2025).